SWS Medical(SH:688410) Xin Lang Zheng Quan·2025-12-01 06:35Core Viewpoint - The stock of Chongqing Shanwaishan Blood Purification Technology Co., Ltd. has experienced fluctuations, with a recent decline of 2.02% and a year-to-date increase of 35.62% [1][2]. Group 1: Stock Performance - As of December 1, the stock price is 15.00 CNY per share, with a market capitalization of 4.794 billion CNY [1]. - The stock has seen a decline of 1.96% over the last five trading days, 11.56% over the last 20 days, and 3.66% over the last 60 days [2]. Group 2: Company Overview - Chongqing Shanwaishan was established on March 26, 2001, and went public on December 26, 2022. The company specializes in the research, production, and sales of blood purification equipment [2]. - The revenue composition is as follows: blood purification equipment 66.12%, blood purification consumables 23.89%, medical services 8.31%, and others 1.68% [2]. Group 3: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 584 million CNY, representing a year-on-year growth of 39.79%. The net profit attributable to shareholders was 104 million CNY, with a year-on-year increase of 68.68% [2]. Group 4: Shareholder Information - As of October 31, the number of shareholders is 11,200, an increase of 8.86% from the previous period, with an average of 20,949 circulating shares per person, a decrease of 8.14% [2]. - The company has distributed a total of 104 million CNY in dividends since its A-share listing [3].